BioMed Central | Articles which cite: Overcoming cisplatin resistance by mTOR inhibitor in lung cancer.

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

Overcoming cisplatin resistance by mTOR inhibitor in lung cancer.
Wu C, Wangpaichitr M, Feun L, Kuo MT, Robles C, Lampidis T, Savaraj N
Mol Cancer 2005, 4:25
[Full text] [PubMed] [Related articles]

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Jiang BH, Liu LZ Drug Resist Updat 2008 Jun, 11:63-76 [PubMed Central] [PubMed] [Related articles]
2.	Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines. Wangpaichitr M, Savaraj N, Maher J, Kurtoglu M, Lampidis TJ Mol Cancer Ther 2008 Jun, 7:1506-13 [PubMed Central] [PubMed] [Related articles]
3.	Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins. Wangpaichitr M, Wu C, You M, Kuo MT, Feun L, Lampidis T, Savaraj N Eur J Pharmacol 2008 Sep 4, 591:124-7 [PubMed Central] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]